Current Report Filing (8-k)
September 12 2022 - 7:01AM
Edgar (US Regulatory)
0001764046
false
00-0000000
0001764046
2022-09-09
2022-09-09
0001764046
us-gaap:CommonStockMember
2022-09-09
2022-09-09
0001764046
us-gaap:SeriesAPreferredStockMember
2022-09-09
2022-09-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (date of earliest event
reported): September 12, 2022 (September 9,
2022)
CLARIVATE PLC
(Exact name of registrant as specified in
its charter)
Jersey, Channel Islands
(State
or other jurisdiction of incorporation)
001-38911
(Commission File Number)
N/A
(IRS Employer Identification No.)
30 St. Mary Axe
London
EC3A
8BE
United
Kingdom
(Address of principal executive offices)
Not applicable
(Zip Code)
(44)
207 433 4000
Registrant’s telephone
number, including area code
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of Each Class |
Trading Symbol |
Name of Each Exchange on Which
Registered |
Ordinary
shares, no par value |
CLVT |
New York Stock Exchange |
5.25% Series A Mandatory Convertible Preferred Shares, no par value |
CLVT PR A |
New York Stock Exchange |
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ¨
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 7.01. |
Regulation FD Disclosure. |
On
September 12, 2022, Clarivate Plc (the “Company” or “Clarivate”) issued a press release announcing
the transaction described under Item 8.01 below, which is furnished as Exhibit 99.1 hereto and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and shall not be incorporated by reference into any registration statement or other document pursuant to
the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.
On
September 9, 2022, Camelot UK Bidco Limited, a wholly owned indirect subsidiary of the Company, entered into a definitive agreement with
Newfold Digital, Inc. (the “Buyer”) to sell the Company’s MarkMonitor domain management business to the Buyer for an
aggregate purchase price of approximately $302.5 million. The agreement contemplates delayed closings in China and Japan pending
completion of certain country-specific closing conditions. Of the purchase price, $292.5 million will be
payable at the initial closing, subject to certain adjustments, and $10 million will be payable upon the completion of all deferred closings.
The initial closing is expected to occur in the fourth quarter of 2022, subject to the receipt of required regulatory approvals
and the satisfaction of other customary closing conditions.
Forward-Looking Statements
This report
contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking
statements are neither historical facts nor assurances of future performance. Instead, they are based only on management’s current
beliefs, expectations, and assumptions regarding our ability to close the transaction and to realize the expected synergies of the transaction,
as well as the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other
future conditions. Because forward-looking statements relate to the future, they are difficult to predict and many are outside of our
control. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the
forward-looking statements are discussed under the caption “Risk Factors” in our 2021 Annual Report on Form 10-K, along with
our other filings with the Securities and Exchange Commission (“SEC”). However, those factors should not be considered to
be a complete statement of all potential risks and uncertainties. Additional risks and uncertainties not known to us or that we currently
deem immaterial may also impair our business operations. Forward-looking statements are based only on information currently available
to our management and speak only as of the date of this report. We do not assume any obligation to publicly provide revisions or updates
to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change,
except as otherwise required by securities and other applicable laws. Please consult our public filings with the SEC or our website at
www.clarivate.com.
Item 9.01. |
Financial Statements and Exhibits. |
(d) Exhibits
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
CLARIVATE PLC |
|
|
Date: September 12, 2022 |
By: |
/s/ Jonathan Collins |
|
Name: |
Jonathan Collins |
|
Title: |
Executive Vice President and Chief Financial Officer |
Clarivate (NYSE:CCC)
Historical Stock Chart
From Jan 2025 to Feb 2025
Clarivate (NYSE:CCC)
Historical Stock Chart
From Feb 2024 to Feb 2025